Skip to main content

Panel Discussion: Case for Standards

You Spoke. We Listened. Together, it’s Time to Act.

The Global Biological Standards Institute (GBSI) Convenes Stakeholders to Solve the Critical Challenge of Irreproducibility in Life Science Research.


GBSI presented the latest findings on irreproducibility obtained from almost 60 interviews with stakeholders throughout the life science community and our recommendations for meaningful change. Plan on joining us for an interactive session on a path forward.

Download The Case for Standards white paper

Download The Case Media Backgrounder

View the Recording: The recording will be available later this week.

Panels and Moderator:

  • C. Glenn Begley, PhD, Chief Science Officer and SVP, TetraLogic Pharmaceuticals
  • Mary Lou Gantzer, PhD, President, Clinical and Laboratory Standards Institute (CLSI)
  • William Bentley, PhD, Professor and Chair, Fischell Department of Bioengineering, University of Maryland
  • Yvonne Reid, PhD Manager/Scientist, American Type Culture Collection
  • Moderator: Leonard Freedman, PhD President, Global Biological Standards Institute (GBSI)

About GBSI

Global Biological Standards Institute (GBSI) advances life science standards to enhance global health.  Through policy initiatives, thought leadership, and education, GBSI seeks to expand the development and adoption of standards in support of credible, reproducible, and translatable outcomes in life science research.  The Washington, DC-based institute provides an independent forum for government, non-governmental organizations, industry, academia, and other stakeholders to ensure that biological standards development is focused on priority needs.